CC
CLPT icon

Centiva Capital’s ClearPoint Neuro CLPT Stock Holding History

Centiva Capital’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-17,363
Closed -$195K – 1779
2024
Q3 		$195K Sell
17,363
-21,836
-56% -$209K ﹤0.01% 1831
2024
Q2 		$211K Buy
+39,199
New +$227K ﹤0.01% 1661

Other funds holding CLPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Centiva Capital's CLPT Position: Q4 2024 in Review

Centiva Capital sold out of ClearPoint Neuro (CLPT) in Q4 2024, closing a stake of 17,363 shares — an estimated $195K sold.

Centiva Capital first reported a position in CLPT in Q2 2024 and held it in 2 quarters. The position peaked at $211K in Q2 2024. 89 funds tracked by Wall St. Rank hold CLPT as of Q4 2024.

  • Centiva Capital reported no remaining ClearPoint Neuro position as of Q4 2024 after selling out during the quarter.
  • Centiva Capital sold 17,363 ClearPoint Neuro shares in Q4 2024, an estimated $195K.
  • Centiva Capital first reported a position in ClearPoint Neuro in Q2 2024 and held it in 2 quarters.
  • Centiva Capital's ClearPoint Neuro position peaked at $211K in Q2 2024.
  • 89 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q4 2024.

Based on Centiva Capital's 13F filing for Q4 2024, filed 14 Feb 2025.